3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
8
Unknown
3
Active not recruiting
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
32
INDUSTRY
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Metabolic Diseases
1
Infertility
1
Interventions
Drug Therapy
10
pembrolizumab
9
Bevacizumab
9
Radiotherapy
8
Cyclophosphamide
8
Carboplatin
8
Oxaliplatin
7
tislelizumab
6
Surgical Procedures, Operative
6
Docetaxel
6
Cisplatin
6
Capecitabine
6
Paclitaxel
5
Nivolumab
5
Fluorouracil
5
Control Groups
5
fludarabine
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Endoscopic Mucosal Resection
4
sintilimab
3
Trastuzumab
3
Pemetrexed
3
Neoadjuvant Therapy
3
Leucovorin
3
Laparoscopy
3
Irinotecan
3
Injections
3
Hematologic Tests
3
HMPL-013
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
Metformin
×
Clear all
NCT07399535
2026-02-10
PCOS
Jinnah Postgraduate Medical Centre
Phase 1
Recruiting
116 enrolled